Furthermore, overexpression of CMTM1 in the glioma cell line A172 promotes tumor cell proliferation and migration, possibly through activation of epidermal growth factor receptor (EGFR), SRC kinase, and WNT signaling pathways (Wu et al., 2019). The gene discussed is EGFR; the disease is central nervous system cancer.